国家药监局药审中心关于发布《用于产生真实世界证据的真实世界数据指导原则(试行)》

2021-04-15 国家药品监督管理局药品审评中心 国家药品监督管理局药品审评中心

为进一步指导和规范申办者利用真实世界数据生成真实世界证据支持药物研发,药审中心组织制定了《用于产生真实世界证据的真实世界数据指导原则(试行)》(见附件)。

为进一步指导和规范申办者利用真实世界数据生成真实世界证据支持药物研发,药审中心组织制定了《用于产生真实世界证据的真实世界数据指导原则(试行)》(见附件)。根据《国家药监局综合司关于印发药品技术指导原则发布程序的通知》(药监综药管〔2020〕9号)要求,经国家药品监督管理局审查同意,现予发布,自发布之日起施行。具体请点击《用于产生真实世界证据的真实世界数据指导原则(试行)》
                                                                                                                           

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
    2021-08-17 ms7000000196251456

    非常实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
    2021-05-31 RachelZ

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
    2021-04-21 滚滚兔🐰

    感谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
    2021-04-19 ms4000001849762959

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
    2021-04-17 xuyu
  9. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=1008741, encodeId=ec1f1008e41cb, content=非常实用, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1db5402696, createdName=ms7000000196251456, createdTime=Tue Aug 17 16:01:09 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1718891, encodeId=3d1e1e188914e, content=<a href='/topic/show?id=e4f58e54594' target=_blank style='color:#2F92EE;'>#药审中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87545, encryptionId=e4f58e54594, topicName=药审中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e0532658924, createdName=nakerunner, createdTime=Wed Jul 07 00:07:15 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1707899, encodeId=498e1e0789988, content=<a href='/topic/show?id=9abc8e543b2' target=_blank style='color:#2F92EE;'>#药审#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87543, encryptionId=9abc8e543b2, topicName=药审)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e54731497337, createdName=h.y200607_23674428, createdTime=Wed Aug 04 21:07:15 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969937, encodeId=9f4f96993e2a, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38cc5481420, createdName=RachelZ, createdTime=Mon May 31 20:52:47 CST 2021, time=2021-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959081, encodeId=beca9590812d, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210121/3066131e88ca4c31a238db2bedac2f10/1d8e8a6a6c4c4256b2b4a24b6723d68a.jpg, createdBy=91092531490, createdName=滚滚兔🐰, createdTime=Wed Apr 21 16:28:32 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958377, encodeId=93d89583e7a8, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210419/5ead015b1e9a46858d1d2664ca40db20/156b8f94028a481a95215f4969d61978.jpg, createdBy=7fa35469147, createdName=ms4000001849762959, createdTime=Mon Apr 19 15:04:40 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295300, encodeId=3db512953008f, content=<a href='/topic/show?id=0425e2636b8' target=_blank style='color:#2F92EE;'>#真实世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72636, encryptionId=0425e2636b8, topicName=真实世界)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b34252, createdName=chenshujs, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429276, encodeId=095d14292e69d, content=<a href='/topic/show?id=321a409e058' target=_blank style='color:#2F92EE;'>#国家药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40970, encryptionId=321a409e058, topicName=国家药监局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b1e4178198, createdName=pyaili, createdTime=Sat Apr 17 09:07:15 CST 2021, time=2021-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957581, encodeId=c19095e5815f, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200831/fb689c3e816d4a64820d63f72073eef4/29c665e5fc1341a9ae58ecf5b979aef9.jpg, createdBy=7e215414767, createdName=ANNA1, createdTime=Fri Apr 16 14:14:27 CST 2021, time=2021-04-16, status=1, ipAttribution=)]
    2021-04-16 ANNA1

    感谢分享

    0